Evotec SE, DE0005664809

Evotec stock heads into the open after a 1.4 percent gain

Published on 09/23/2026 at 09:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Evotec stock was reported at EUR 2.83 on Xetra, 1.4 percent higher during the session, while the DAX gained 0.02 percent. A company conference appearance is scheduled today.

Fotorealistisches Pharma-Labor mit Wissenschaftlern bei Wirkstoffscreening in moderner Biotech-Anlage
Fotorealistisches Pharma-Labor symbolisiert Wirkstoffforschung von Evotec SE, ISIN DE0005664809, moderner Biotech-Standort Hamburg, Illustration mit AI erstellt.

Evotec stock was reported at EUR 2.83 on Xetra on September 22, 2026, up 1.4 percent during the session. The gain exceeded the DAX advance of 0.02 percent, a difference of 1.38 percentage points.

September 22, 2026 in numbers

Evotec SE (ISIN DE0005664809, Xetra: EVT) traded at EUR 2.83 during the September 22, 2026 session after reaching a new 52-week low of EUR 2.73. The latest completed Xetra close explicitly available was EUR 2.79 on September 21, 2026, down 4.12 percent, while the September 22 session report identified the EUR 2.83 quotation as 1.4 percent higher at 10:28 a.m. ET.

The shares remained EUR 4.47 below the reported 52-week high of EUR 7.30 recorded on October 27, 2025. The Nasdaq Composite closed at 27,122.09 on September 22, 2026, up 2.3 percent, providing a separate comparison for Evotec's ADR-linked US security.

Conference appearance today

Evotec is scheduled to present at BioProcess International US East 2026 in Boston on September 23 and September 24, 2026, as Ad hoc news reported on September 22, 2026.

Disclaimer...

en | DE0005664809 | EVOTEC SE | boerse | 70164176 | bgmi